373 related articles for article (PubMed ID: 18336925)
21. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
[TBL] [Abstract][Full Text] [Related]
22. Resistance testing of clinical varicella-zoster virus strains.
Sauerbrei A; Taut J; Zell R; Wutzler P
Antiviral Res; 2011 Jun; 90(3):242-7. PubMed ID: 21539861
[TBL] [Abstract][Full Text] [Related]
23. Detection and differentiation of herpes simplex virus types 1 and 2 by a duplex LightCycler PCR that incorporates an internal control PCR reaction.
Whiley DM; Mackay IM; Syrmis MW; Witt MJ; Sloots TP
J Clin Virol; 2004 May; 30(1):32-8. PubMed ID: 15072751
[TBL] [Abstract][Full Text] [Related]
24. Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey.
Burrel S; Aime C; Hermet L; Ait-Arkoub Z; Agut H; Boutolleau D
Antiviral Res; 2013 Nov; 100(2):365-72. PubMed ID: 24075863
[TBL] [Abstract][Full Text] [Related]
25. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.
Burrel S; Boutolleau D; Azar G; Doan S; Deback C; Cochereau I; Agut H; Gabison EE
J Clin Virol; 2013 Sep; 58(1):321-4. PubMed ID: 23731845
[TBL] [Abstract][Full Text] [Related]
27. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
[TBL] [Abstract][Full Text] [Related]
28. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
29. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis.
Duan R; de Vries RD; van Dun JM; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2009 Nov; 200(9):1402-14. PubMed ID: 19795980
[TBL] [Abstract][Full Text] [Related]
30. Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues.
Bestman-Smith J; Schmit I; Papadopoulou B; Boivin G
J Virol; 2001 Apr; 75(7):3105-10. PubMed ID: 11238837
[TBL] [Abstract][Full Text] [Related]
31. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
Schmit I; Boivin G
J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
[TBL] [Abstract][Full Text] [Related]
33. Biochemical characterization of a virus isolate, recovered from a patient with herpes keratitis, that was clinically resistant to acyclovir.
Sarisky RT; Cano R; Nguyen TT; Wittrock RJ; Duffy KE; Clark P; Bartus JO; Bacon TH; Caspers-Velu L; Hodinka RL; Leary JJ
Clin Infect Dis; 2001 Dec; 33(12):2034-9. PubMed ID: 11712095
[TBL] [Abstract][Full Text] [Related]
34. Long-term observation of herpes simplex virus type 1 (HSV-1) infection in a child with Wiskott-Aldrich syndrome and a possible reactivation mechanism for thymidine kinase-negative HSV-1 in humans.
Shiota T; Kurane I; Morikawa S; Saijo M
Jpn J Infect Dis; 2011; 64(2):121-6. PubMed ID: 21519125
[TBL] [Abstract][Full Text] [Related]
35. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.
Burrel S; Deback C; Agut H; Boutolleau D
Antimicrob Agents Chemother; 2010 Nov; 54(11):4833-42. PubMed ID: 20733037
[TBL] [Abstract][Full Text] [Related]
36. Herpes simplex virus resistance to antiviral drugs.
Morfin F; Thouvenot D
J Clin Virol; 2003 Jan; 26(1):29-37. PubMed ID: 12589832
[TBL] [Abstract][Full Text] [Related]
37. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient.
Lebel A; Boivin G
J Clin Virol; 2006 Sep; 37(1):34-7. PubMed ID: 16781887
[TBL] [Abstract][Full Text] [Related]
38. Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in France.
Frobert E; Burrel S; Ducastelle-Lepretre S; Billaud G; Ader F; Casalegno JS; Nave V; Boutolleau D; Michallet M; Lina B; Morfin F
Antiviral Res; 2014 Nov; 111():36-41. PubMed ID: 25218782
[TBL] [Abstract][Full Text] [Related]
39. Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity.
Burrel S; Bonnafous P; Hubacek P; Agut H; Boutolleau D
Antiviral Res; 2012 Dec; 96(3):386-90. PubMed ID: 23041200
[TBL] [Abstract][Full Text] [Related]
40. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
